| 1.81 -0.08 (-4.23%) | 01-29 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.28 | 1-year : | 2.66 |
| Resists | First : | 1.95 | Second : | 2.28 |
| Pivot price | 1.66  |
|||
| Supports | First : | 1.58 | Second : | 1.36 |
| MAs | MA(5) : | 1.83 |
MA(20) : | 1.63 |
| MA(100) : | 1.86 |
MA(250) : | 1.85 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 81 |
D(3) : | 88.5 |
| RSI | RSI(14): 61.4 |
|||
| 52-week | High : | 3.21 | Low : | 1.03 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MDAI ] has closed below upper band by 21.4%. Bollinger Bands are 1.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.87 - 1.88 | 1.88 - 1.89 |
| Low: | 1.71 - 1.72 | 1.72 - 1.73 |
| Close: | 1.79 - 1.81 | 1.81 - 1.83 |
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Tue, 27 Jan 2026
Spectral AI, Inc. (NASDAQ:MDAI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry - simplywall.st
Sun, 30 Nov 2025
An Intrinsic Calculation For Spectral AI, Inc. (NASDAQ:MDAI) Suggests It's 25% Undervalued - Yahoo Finance
Fri, 28 Nov 2025
The Market Doesn't Like What It Sees From Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Yet As Shares Tumble 27% - simplywall.st
Wed, 12 Nov 2025
Spectral AI stock price target lowered to $3 by BTIG on revenue miss - Investing.com
Wed, 12 Nov 2025
BTIG Maintains Spectral AI (MDAI) Buy Recommendation - Nasdaq
Tue, 11 Nov 2025
Spectral AI, Inc. Reports Q3 2025 Financial Results and Advances in FDA Submission with Strong Cash Position - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 31 (M) |
| Shares Float | 23 (M) |
| Held by Insiders | 25.6 (%) |
| Held by Institutions | 9.6 (%) |
| Shares Short | 1,390 (K) |
| Shares Short P.Month | 1,350 (K) |
| EPS | -0.75 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.31 |
| Profit Margin | -70.7 % |
| Operating Margin | -88.2 % |
| Return on Assets (ttm) | -34.8 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -53.6 % |
| Gross Profit (p.s.) | 0.33 |
| Sales Per Share | 0.75 |
| EBITDA (p.s.) | -0.25 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | 5 (M) |
| PE Ratio | -2.42 |
| PEG Ratio | 0 |
| Price to Book value | -6.04 |
| Price to Sales | 2.39 |
| Price to Cash Flow | -8.06 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|